- Home
- PPBT vs AEI Comparison
PPBT vs AEI Comparison
Compare PPBT & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- AEI
- Stock Information
- Founded
- PPBT 2010
- AEI 2014
- Country
- PPBT Israel
- AEI United States
- Employees
- PPBT N/A
- AEI N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- AEI Building operators
- Sector
- PPBT Health Care
- AEI Real Estate
- Exchange
- PPBT Nasdaq
- AEI Nasdaq
- Market Cap
- PPBT 8.7M
- AEI 9.4M
- IPO Year
- PPBT N/A
- AEI N/A
- Fundamental
- Price
- PPBT $3.17
- AEI $1.03
- Analyst Decision
- PPBT Strong Buy
- AEI
- Analyst Count
- PPBT 2
- AEI 0
- Target Price
- PPBT $126.50
- AEI N/A
- AVG Volume (30 Days)
- PPBT 23.2K
- AEI 260.8K
- Earning Date
- PPBT 03-07-2025
- AEI 03-31-2025
- Dividend Yield
- PPBT N/A
- AEI N/A
- EPS Growth
- PPBT N/A
- AEI N/A
- EPS
- PPBT N/A
- AEI N/A
- Revenue
- PPBT N/A
- AEI $13,191,488.00
- Revenue This Year
- PPBT N/A
- AEI N/A
- Revenue Next Year
- PPBT N/A
- AEI N/A
- P/E Ratio
- PPBT N/A
- AEI N/A
- Revenue Growth
- PPBT N/A
- AEI N/A
- 52 Week Low
- PPBT $2.00
- AEI $0.46
- 52 Week High
- PPBT $20.60
- AEI $2.61
- Technical
- Relative Strength Index (RSI)
- PPBT 44.15
- AEI 51.10
- Support Level
- PPBT $3.01
- AEI $1.03
- Resistance Level
- PPBT $3.48
- AEI $1.18
- Average True Range (ATR)
- PPBT 0.22
- AEI 0.11
- MACD
- PPBT 0.03
- AEI 0.01
- Stochastic Oscillator
- PPBT 52.63
- AEI 40.43
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.